Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 4/2014

01-06-2014 | Original Paper

Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders

Authors: Shigeto Nagao, Osamu Yokota, Chikako Ikeda, Naoya Takeda, Hideki Ishizu, Shigetoshi Kuroda, Koichiro Sudo, Seishi Terada, Shigeo Murayama, Yosuke Uchitomi

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 4/2014

Login to get access

Abstract

To study the relationship between neurodegenerative diseases including argyrophilic grain disease (AGD) and late-onset schizophrenia and delusional disorders (LOSD; onset ≥40 years of age), we pathologically examined 23 patients with LOSD, 71 age-matched normal controls, and 22 psychiatric disease controls (11 depression, six personality disorder, two bipolar disorders, and three neurotic disorders cases). In all LOSD cases (compared to age-matched normal controls), the frequencies of Lewy body disease (LBD), AGD, and corticobasal degeneration (CBD) were 26.1 % (11.3 %), 21.7 % (8.5 %), and 4.3 % (0.0 %), respectively. There was no case of pure Alzheimer’s disease (AD). The total frequency of LBD, AGD, and CBD was significantly higher in LOSD cases than in normal controls. Argyrophilic grains were significantly more severe in LOSD than in controls, but were almost completely restricted to the limbic system and adjacent temporal cortex. In LOSD patients whose onset occurred at ≥65 years of age (versus age-matched normal controls), the frequencies of LBD and AGD were 36.4 % (19.4 %) and 36.4 % (8.3 %), respectively, and AGD was significantly more frequent in LOSD patients than in normal controls. In LOSD patients whose onset occurred at <65 years of age, the frequencies of LBD, AGD, and CBD were 16.7, 8.3, and 8.3 %, comparable to those of age-matched normal controls (10.2, 5.1, and 0.0 %). In all psychiatric cases, delusion was significantly more frequent in AGD cases than in cases bearing minimal AD pathology alone. Given these findings, LOSD patients may have heterogeneous pathological backgrounds, and AGD may be associated with the occurrence of LOSD especially after 65 years of age.
Literature
1.
go back to reference Sadock BJ, Sadock VA (2003) Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia Sadock BJ, Sadock VA (2003) Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia
2.
go back to reference American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision (DSM-IV-TR), American Psychiatric Association, Washington DC American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text revision (DSM-IV-TR), American Psychiatric Association, Washington DC
3.
go back to reference Bleuler M (1943) Late schizophrenic clinical pictures. Fortschr Neurol Psychiatr 15:259–290 Bleuler M (1943) Late schizophrenic clinical pictures. Fortschr Neurol Psychiatr 15:259–290
4.
go back to reference Howard R, Castle D, Wessely S, Murray R (1993) A comparative study of 470 cases of early-onset and late-onset schizophrenia. Br J Psychiatry 163:352–357PubMedCrossRef Howard R, Castle D, Wessely S, Murray R (1993) A comparative study of 470 cases of early-onset and late-onset schizophrenia. Br J Psychiatry 163:352–357PubMedCrossRef
5.
go back to reference Howard R, Almeida O, Levy R (1994) Phenomenology, demography and diagnosis in late paraphrenia. Psychol Med 24:397–410PubMedCrossRef Howard R, Almeida O, Levy R (1994) Phenomenology, demography and diagnosis in late paraphrenia. Psychol Med 24:397–410PubMedCrossRef
6.
go back to reference Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, Schlaepfer TB, Tune LE (1989) A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 146:1568–1574PubMed Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, Schlaepfer TB, Tune LE (1989) A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 146:1568–1574PubMed
7.
go back to reference Rabins P, Pauker S, Thomas J (1984) Can schizophrenia begin after age 44? Compr Psychiatry 25:290–293PubMedCrossRef Rabins P, Pauker S, Thomas J (1984) Can schizophrenia begin after age 44? Compr Psychiatry 25:290–293PubMedCrossRef
8.
go back to reference Riecher-Rössler A, Löffler W, Munk-Jørgensen P (1997) What do we really know about late-onset schizophrenia? Eur Arch Psychiatry Clin Neurosci 247:195–208PubMedCrossRef Riecher-Rössler A, Löffler W, Munk-Jørgensen P (1997) What do we really know about late-onset schizophrenia? Eur Arch Psychiatry Clin Neurosci 247:195–208PubMedCrossRef
9.
go back to reference Rajji TK, Ismail Z, Mulsant BH (2009) Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry 195:286–293PubMedCrossRef Rajji TK, Ismail Z, Mulsant BH (2009) Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry 195:286–293PubMedCrossRef
10.
go back to reference Howard R, Rabins PV, Seeman MV, Jeste DV (2000) Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 157:172–178PubMedCrossRef Howard R, Rabins PV, Seeman MV, Jeste DV (2000) Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 157:172–178PubMedCrossRef
11.
go back to reference Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 54:915–922PubMedCrossRef Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M (1997) ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 54:915–922PubMedCrossRef
12.
go back to reference Fujikawa T, Yamawaki S, Touhouda Y (1993) Incidence of silent cerebral infarction in patients with major depression. Stroke 24:1631–1634PubMedCrossRef Fujikawa T, Yamawaki S, Touhouda Y (1993) Incidence of silent cerebral infarction in patients with major depression. Stroke 24:1631–1634PubMedCrossRef
13.
go back to reference Stewart R, Prince M, Mann A, Richards M, Brayne C (2001) Stroke, vascular risk factors and depression: cross-sectional study in a UK Caribbean-born population. Br J Psychiatry 178:23–28PubMedCrossRef Stewart R, Prince M, Mann A, Richards M, Brayne C (2001) Stroke, vascular risk factors and depression: cross-sectional study in a UK Caribbean-born population. Br J Psychiatry 178:23–28PubMedCrossRef
14.
go back to reference Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O’Brien JT (2001) A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry 70:83–87PubMedCentralPubMedCrossRef Thomas AJ, Ferrier IN, Kalaria RN, Perry RH, Brown A, O’Brien JT (2001) A neuropathological study of vascular factors in late-life depression. J Neurol Neurosurg Psychiatry 70:83–87PubMedCentralPubMedCrossRef
15.
go back to reference Krishnan KR, McDonald WM, Doraiswamy PM, Tupler LA, Husain M, Boyko OB, Figiel GS, Ellinwood EH Jr (1993) Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci 243:41–46PubMedCrossRef Krishnan KR, McDonald WM, Doraiswamy PM, Tupler LA, Husain M, Boyko OB, Figiel GS, Ellinwood EH Jr (1993) Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry Clin Neurosci 243:41–46PubMedCrossRef
16.
go back to reference Förstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R (1992) Clinical and neuropathological correlates of depression in Alzheimer’s disease. Psychol Med 22:877–884PubMedCrossRef Förstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R (1992) Clinical and neuropathological correlates of depression in Alzheimer’s disease. Psychol Med 22:877–884PubMedCrossRef
17.
go back to reference Gibb WR, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131–1153PubMedCrossRef Gibb WR, Esiri MM, Lees AJ (1987) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 110:1131–1153PubMedCrossRef
18.
go back to reference Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology 47:1148–1152PubMedCrossRef Klatka LA, Louis ED, Schiffer RB (1996) Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer’s disease and Parkinson’s disease comparison groups. Neurology 47:1148–1152PubMedCrossRef
19.
go back to reference Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE, Medical Research Council Cognitive Function and Ageing Study (2011) Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:109–114PubMedCrossRef Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE, Medical Research Council Cognitive Function and Ageing Study (2011) Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:109–114PubMedCrossRef
20.
go back to reference Xekardaki A, Santos M, Hof P, Kövari E, Bouras C, Giannakopoulos P (2012) Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 124:453–464PubMedCrossRef Xekardaki A, Santos M, Hof P, Kövari E, Bouras C, Giannakopoulos P (2012) Neuropathological substrates and structural changes in late-life depression: the impact of vascular burden. Acta Neuropathol 124:453–464PubMedCrossRef
21.
go back to reference Jellinger KA (2013) Organic bases of late-life depression: a critical update. J Neural Transm 120:1109–1125PubMedCrossRef Jellinger KA (2013) Organic bases of late-life depression: a critical update. J Neural Transm 120:1109–1125PubMedCrossRef
22.
go back to reference Jellinger KA, Gabriel E (1999) No increased incidence of Alzheimer’s disease in elderly schizophrenics. Acta Neuropathol 97:165–169PubMedCrossRef Jellinger KA, Gabriel E (1999) No increased incidence of Alzheimer’s disease in elderly schizophrenics. Acta Neuropathol 97:165–169PubMedCrossRef
23.
go back to reference Jellinger KA (2009) Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol 117:423–427PubMedCrossRef Jellinger KA (2009) Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol 117:423–427PubMedCrossRef
24.
go back to reference Casanova MF, Stevens JR, Brown R, Royston C, Bruton C (2002) Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol 103:313–320PubMedCrossRef Casanova MF, Stevens JR, Brown R, Royston C, Bruton C (2002) Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol 103:313–320PubMedCrossRef
25.
go back to reference Bozikas VP, Kövari E, Bouras C, Karavatos A (2002) Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci Lett 324:109–112PubMedCrossRef Bozikas VP, Kövari E, Bouras C, Karavatos A (2002) Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci Lett 324:109–112PubMedCrossRef
26.
go back to reference Casanova MF (2003) Preservation of hippocampal pyramidal cells in paraphrenia. Schizophr Res 62:141–146PubMedCrossRef Casanova MF (2003) Preservation of hippocampal pyramidal cells in paraphrenia. Schizophr Res 62:141–146PubMedCrossRef
27.
go back to reference Birkett DP, Desouky A, Han L, Kaufman M (1992) Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry 7:235–240CrossRef Birkett DP, Desouky A, Han L, Kaufman M (1992) Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry 7:235–240CrossRef
28.
go back to reference Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:42–49PubMedCrossRef Aarsland D, Litvan I, Larsen JP (2001) Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 13:42–49PubMedCrossRef
29.
go back to reference Geda YE, Boeve BF, Negash S, Graff-Radford NR, Knopman DS, Parisi JE, Dickson DW, Petersen RC (2007) Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 19:77–80PubMedCrossRef Geda YE, Boeve BF, Negash S, Graff-Radford NR, Knopman DS, Parisi JE, Dickson DW, Petersen RC (2007) Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 19:77–80PubMedCrossRef
30.
go back to reference Josephs KA, Dickson DW (2003) Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 18:1018–1026PubMedCrossRef Josephs KA, Dickson DW (2003) Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 18:1018–1026PubMedCrossRef
31.
go back to reference Togo T, Isojima D, Akatsu H, Suzuki K, Uchikado H, Katsuse O, Iseki E, Kosaka K, Hirayasu Y (2005) Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 13:1083–1091PubMedCrossRef Togo T, Isojima D, Akatsu H, Suzuki K, Uchikado H, Katsuse O, Iseki E, Kosaka K, Hirayasu Y (2005) Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms. Am J Geriatr Psychiatry 13:1083–1091PubMedCrossRef
32.
go back to reference Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801–819PubMedCrossRef Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 105:801–819PubMedCrossRef
33.
go back to reference Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911–918PubMed Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, Kakuta Y, Yamanouchi H, Murayama S (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63:911–918PubMed
34.
go back to reference Asaoka T, Tsuchiya K, Fujishiro H, Arai T, Hasegawa M, Akiyama H, Iseki E, Oda T, Onaya M, Tominaga I (2010) Argyrophilic grain disease with delusions and hallucinations: a pathological study. Psychogeriatrics 10:69–76PubMedCrossRef Asaoka T, Tsuchiya K, Fujishiro H, Arai T, Hasegawa M, Akiyama H, Iseki E, Oda T, Onaya M, Tominaga I (2010) Argyrophilic grain disease with delusions and hallucinations: a pathological study. Psychogeriatrics 10:69–76PubMedCrossRef
35.
go back to reference Ikeda K, Akiyama H, Arai T, Matsushita M, Tsuchiya K, Miyazaki H (2000) Clinical aspects of argyrophilic grain disease. Clin Neuropathol 19:278–284PubMed Ikeda K, Akiyama H, Arai T, Matsushita M, Tsuchiya K, Miyazaki H (2000) Clinical aspects of argyrophilic grain disease. Clin Neuropathol 19:278–284PubMed
36.
go back to reference Ishihara K, Araki S, Ihori N, Shiota J, Kawamura M, Yoshida M, Hashizume Y, Nakano I (2005) Argyrophilic grain disease presenting with frontotemporal dementia: a neuropsychological and pathological study of an autopsied case with presenile onset. Neuropathology 25:165–170PubMedCrossRef Ishihara K, Araki S, Ihori N, Shiota J, Kawamura M, Yoshida M, Hashizume Y, Nakano I (2005) Argyrophilic grain disease presenting with frontotemporal dementia: a neuropsychological and pathological study of an autopsied case with presenile onset. Neuropathology 25:165–170PubMedCrossRef
37.
go back to reference Maurage CA, Sergeant N, Schraen-Maschke S, Lebert F, Ruchoux MM, Sablonnière B, Pasquier F, Delacourte A (2003) Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol 106:575–583PubMedCrossRef Maurage CA, Sergeant N, Schraen-Maschke S, Lebert F, Ruchoux MM, Sablonnière B, Pasquier F, Delacourte A (2003) Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol 106:575–583PubMedCrossRef
38.
go back to reference Tsuchiya K, Mitani K, Arai T, Yamada S, Komiya T, Esaki Y, Haga C, Yamanouchi H, Ikeda K (2001) Argyrophilic grain disease mimicking temporal Pick’s disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol 102:195–199PubMedCrossRef Tsuchiya K, Mitani K, Arai T, Yamada S, Komiya T, Esaki Y, Haga C, Yamanouchi H, Ikeda K (2001) Argyrophilic grain disease mimicking temporal Pick’s disease: a clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol 102:195–199PubMedCrossRef
39.
go back to reference Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55–66PubMedCentralPubMedCrossRef Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, Arai T, Hasegawa M, Akiyama H, Sikkink S, Pickering-Brown S, Mann DM (2010) Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 120:55–66PubMedCentralPubMedCrossRef
40.
go back to reference Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCentralPubMedCrossRef Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404PubMedCentralPubMedCrossRef
41.
go back to reference Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef
42.
go back to reference Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedCrossRef Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMedCrossRef
43.
go back to reference The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. Neurobiol Aging 18(4 Suppl):S1–S2 The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. Neurobiol Aging 18(4 Suppl):S1–S2
44.
go back to reference Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging, Alzheimer’s Association (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11PubMedCentralPubMedCrossRef Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging, Alzheimer’s Association (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11PubMedCentralPubMedCrossRef
45.
go back to reference McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMedCrossRef McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872PubMedCrossRef
46.
go back to reference Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697PubMedCrossRef Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697PubMedCrossRef
47.
go back to reference Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I, Office of Rare Diseases of the National Institutes of Health (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946PubMed Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I, Office of Rare Diseases of the National Institutes of Health (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946PubMed
48.
go back to reference Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019PubMedCrossRef Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019PubMedCrossRef
49.
go back to reference Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445PubMedCentralPubMedCrossRef Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445PubMedCentralPubMedCrossRef
50.
go back to reference Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575PubMedCrossRef Yokota O, Tsuchiya K, Terada S, Ishizu H, Uchikado H, Ikeda M, Oyanagi K, Nakano I, Murayama S, Kuroda S, Akiyama H (2008) Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: a comparative clinicopathological study. Acta Neuropathol 115:561–575PubMedCrossRef
51.
go back to reference Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, Mochizuki A, Tamaoka A, Kawamura M, Yoshida H, Terada S, Ishizu H, Kuroda S, Akiyama H (2009) Clinicopathological characterization of Pick’s disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 117:429–444PubMedCrossRef Yokota O, Tsuchiya K, Arai T, Yagishita S, Matsubara O, Mochizuki A, Tamaoka A, Kawamura M, Yoshida H, Terada S, Ishizu H, Kuroda S, Akiyama H (2009) Clinicopathological characterization of Pick’s disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 117:429–444PubMedCrossRef
52.
go back to reference Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Hoftberger R, Fraser G, Crowther RA, Goedert M, Budka H, Ghetti B (2008) White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 67:963–975PubMedCentralPubMedCrossRef Kovacs GG, Majtenyi K, Spina S, Murrell JR, Gelpi E, Hoftberger R, Fraser G, Crowther RA, Goedert M, Budka H, Ghetti B (2008) White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration. J Neuropathol Exp Neurol 67:963–975PubMedCentralPubMedCrossRef
53.
go back to reference Yamada M (2003) Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 23:311–317PubMedCrossRef Yamada M (2003) Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology 23:311–317PubMedCrossRef
54.
go back to reference Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374–382PubMedCrossRef Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374–382PubMedCrossRef
55.
go back to reference Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969PubMedCrossRef Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969PubMedCrossRef
56.
go back to reference Cummings JL (1985) Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry 146:184–197PubMedCrossRef Cummings JL (1985) Organic delusions: phenomenology, anatomical correlations, and review. Br J Psychiatry 146:184–197PubMedCrossRef
57.
go back to reference Cummings JL, Mega MS (eds) (2003) Psychosis, delusion, and schizophrenia. In: Neuropsychiatry and behavioral neuroscience. Oxford University Press, New York, pp 172–186 Cummings JL, Mega MS (eds) (2003) Psychosis, delusion, and schizophrenia. In: Neuropsychiatry and behavioral neuroscience. Oxford University Press, New York, pp 172–186
58.
go back to reference McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22:911–922PubMedCrossRef McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22:911–922PubMedCrossRef
60.
go back to reference Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16:528–536PubMedCrossRef Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16:528–536PubMedCrossRef
61.
go back to reference Perneczky R, Drzezga A, Boecker H, Förstl H, Kurz A, Häussermann P (2008) Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 25:531–538PubMedCrossRef Perneczky R, Drzezga A, Boecker H, Förstl H, Kurz A, Häussermann P (2008) Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord 25:531–538PubMedCrossRef
62.
go back to reference Jellinger KA (2012) Cerebral correlates of psychotic syndromes in neurodegenerative diseases. J Cell Mol Med 2012(16):995–1012CrossRef Jellinger KA (2012) Cerebral correlates of psychotic syndromes in neurodegenerative diseases. J Cell Mol Med 2012(16):995–1012CrossRef
63.
go back to reference Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef
64.
go back to reference Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322PubMedCrossRef Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322PubMedCrossRef
65.
go back to reference Diederich NJ, Leurgans S, Fan W, Chmura TA, Goetz CG (2008) Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry 23:598–603PubMedCrossRef Diederich NJ, Leurgans S, Fan W, Chmura TA, Goetz CG (2008) Visual hallucinations and symptoms of REM sleep behavior disorder in Parkinsonian tauopathies. Int J Geriatr Psychiatry 23:598–603PubMedCrossRef
66.
go back to reference Yatabe Y, Hashimoto M, Kaneda K, Honda K, Ogawa Y, Yuuki S, Matsuzaki S, Tuyuguchi A, Kashiwagi H, Ikeda M (2011) Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. Psychogeriatrics 11:54–59PubMedCrossRef Yatabe Y, Hashimoto M, Kaneda K, Honda K, Ogawa Y, Yuuki S, Matsuzaki S, Tuyuguchi A, Kashiwagi H, Ikeda M (2011) Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. Psychogeriatrics 11:54–59PubMedCrossRef
67.
go back to reference Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230–240PubMedCrossRef Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG (2011) α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10:230–240PubMedCrossRef
68.
go back to reference Luk C, Compta Y, Magdalinou N, Martí MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, Cámara A, Cheshire P, Williams DR, Lees AJ, de Silva R (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem 123:396–405PubMedCrossRef Luk C, Compta Y, Magdalinou N, Martí MJ, Hondhamuni G, Zetterberg H, Blennow K, Constantinescu R, Pijnenburg Y, Mollenhauer B, Trenkwalder C, Van Swieten J, Chiu WZ, Borroni B, Cámara A, Cheshire P, Williams DR, Lees AJ, de Silva R (2012) Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies. J Neurochem 123:396–405PubMedCrossRef
69.
go back to reference Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson’s disease and Dementia with Lewy bodies. Neurobiol Dis 45:188–195PubMedCentralPubMedCrossRef Foulds PG, Yokota O, Thurston A, Davidson Y, Ahmed Z, Holton J, Thompson JC, Akiyama H, Arai T, Hasegawa M, Gerhard A, Allsop D, Mann DM (2012) Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson’s disease and Dementia with Lewy bodies. Neurobiol Dis 45:188–195PubMedCentralPubMedCrossRef
Metadata
Title
Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders
Authors
Shigeto Nagao
Osamu Yokota
Chikako Ikeda
Naoya Takeda
Hideki Ishizu
Shigetoshi Kuroda
Koichiro Sudo
Seishi Terada
Shigeo Murayama
Yosuke Uchitomi
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 4/2014
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-013-0472-6

Other articles of this Issue 4/2014

European Archives of Psychiatry and Clinical Neuroscience 4/2014 Go to the issue